Transplantation, HomologousLiver TransplantationBone Marrow TransplantationHematopoietic Stem Cell TransplantationKidney TransplantationTransplantation, AutologousTransplantation ConditioningGraft vs Host DiseaseHeart TransplantationStem Cell TransplantationLung TransplantationGraft SurvivalGraft RejectionTissue DonorsTransplantation ChimeraTransplantation ImmunologyOrgan TransplantationIslets of Langerhans TransplantationTransplantation, IsogeneicPancreas TransplantationTransplantationImmunosuppressive AgentsCell TransplantationTreatment OutcomeHematologic NeoplasmsHistocompatibility TestingSkin TransplantationPeripheral Blood Stem Cell TransplantationCord Blood Stem Cell TransplantationImmunosuppressionTransplantation, HeterotopicTransplantation ToleranceWhole-Body IrradiationHistocompatibilityLiving DonorsRecurrenceRetrospective StudiesTime FactorsIsoantigensT-LymphocytesHeart-Lung TransplantationLeukemiaGraft vs Tumor EffectBusulfanTissue and Organ ProcurementLymphocyte Culture Test, MixedGraft vs Leukemia EffectFetal Tissue TransplantationCyclosporineSurvival AnalysisLiver FailureCorneal TransplantationSurvival RateMice, Inbred C57BLPostoperative ComplicationsRemission InductionHLA AntigensMyeloablative AgonistsTransplantation, HeterologousFollow-Up StudiesTacrolimusGraft vs Host ReactionAnemia, AplasticLymphocyte DepletionAcute DiseaseLeukemia, Myeloid, AcuteCytomegalovirus InfectionsWaiting ListsMice, Inbred BALB CCombined Modality TherapyAntilymphocyte SerumMesenchymal Stem Cell TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTissue TransplantationChimerismVidarabinePrecursor Cell Lymphoblastic Leukemia-LymphomaDonor SelectionCyclophosphamideRadiation ChimeraLeukocyte TransfusionLymphocyte ActivationCadaverImmune ToleranceSpleenHematopoietic Stem CellsMyelodysplastic SyndromesLiver DiseasesBone Marrow CellsRisk FactorsBrain Tissue TransplantationRats, Inbred LewMultiple MyelomaHepatic Veno-Occlusive DiseaseCytotoxicity, ImmunologicHematologic DiseasesBlood Group IncompatibilityFacial TransplantationIsoantibodiesPrognosis